The SWET trial of water softeners for eczema has been used as a case study in a major report assessing the impact of the NIHR Health Technology Assessment (HTA) Programme.
The report by RAND Europe looked at the impact of HTA funded research from 2003 to 2013 on patient health, clinical practice, health policy, the economy and academia.
The SWET trial was included as one of 12 case studies of high-impact research projects, "selected to illustrate the variety and range of impacts arising from HTA projects".
For further information see the news story on the NIHR website.
The University of Nottingham Applied Health Research Building University Park, Nottingham NG7 2RD
telephone: +44 (0) 115 84 68631 email: cebd@nottingham.ac.uk